150 related articles for article (PubMed ID: 9776014)
21. Effects of M274773, a neurokinin-2 receptor antagonist, on bladder function in chronically spinalized rats.
Abdel-Karim AM; Barthlow HG; Bialecki RA; Elhilali MM
J Urol; 2005 Oct; 174(4 Pt 1):1488-92. PubMed ID: 16145477
[TBL] [Abstract][Full Text] [Related]
22. Urodynamic assessment during intravesical infusion of capsaicin for the treatment of refractory detrusor hyperreflexia.
Lazzeri M; Spinelli M; Beneforti P; Zanollo A; Turini D
Spinal Cord; 1999 Jun; 37(6):440-3. PubMed ID: 10432264
[TBL] [Abstract][Full Text] [Related]
23. Intravesical capsaicin in neurologic impaired patients with detrusor hyperreflexia.
Das A; Chancellor MB; Watanabe T; Sedor J; Rivas DA
J Spinal Cord Med; 1996 Jul; 19(3):190-3. PubMed ID: 8819028
[TBL] [Abstract][Full Text] [Related]
24. A pilot randomized-controlled trial of the urodynamic efficacy of mirabegron for patients with neurogenic lower urinary tract dysfunction.
Welk B; Hickling D; McKibbon M; Radomski S; Ethans K
Neurourol Urodyn; 2018 Nov; 37(8):2810-2817. PubMed ID: 30168626
[TBL] [Abstract][Full Text] [Related]
25. Intravesical capsaicin in patients with detrusor hyper-reflexia--a placebo-controlled cross-over study.
Petersen T; Nielsen JB; Schrøder HD
Scand J Urol Nephrol; 1999 Apr; 33(2):104-10. PubMed ID: 10360450
[TBL] [Abstract][Full Text] [Related]
26. Desensitization of bladder sensory fibers by intravesical resiniferatoxin, a capsaicin analog: long-term results for the treatment of detrusor hyperreflexia.
Silva C; Rio ME; Cruz F
Eur Urol; 2000 Oct; 38(4):444-52. PubMed ID: 11025384
[TBL] [Abstract][Full Text] [Related]
27. Urodynamic changes during therapeutic intravesical instillations of capsaicin.
Chandiramani VA; Peterson T; Duthie GS; Fowler CJ
Br J Urol; 1996 Jun; 77(6):792-7. PubMed ID: 8705210
[TBL] [Abstract][Full Text] [Related]
28. The role of capsaicin-sensitive afferents in autonomic dysreflexia in patients with spinal cord injury.
Igawa Y; Satoh T; Mizusawa H; Seki S; Kato H; Ishizuka O; Nishizawa O
BJU Int; 2003 May; 91(7):637-41. PubMed ID: 12699475
[TBL] [Abstract][Full Text] [Related]
29. The effect of intravesical Marcain instillation on hyperreflexic detrusor contractions.
McInerney PD; Grant A; Chawla J; Stephenson TP
Paraplegia; 1992 Feb; 30(2):127-30. PubMed ID: 1589288
[TBL] [Abstract][Full Text] [Related]
30. Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: a dual center study with long-term followup.
De Ridder D; Chandiramani V; Dasgupta P; Van Poppel H; Baert L; Fowler CJ
J Urol; 1997 Dec; 158(6):2087-92. PubMed ID: 9366318
[TBL] [Abstract][Full Text] [Related]
31. Effect of controlled-release oxybutynin on neurogenic bladder function in spinal cord injury.
O'Leary M; Erickson JR; Smith CP; McDermott C; Horton J; Chancellor MB
J Spinal Cord Med; 2003; 26(2):159-62. PubMed ID: 12828295
[TBL] [Abstract][Full Text] [Related]
32. Clinical and urodynamic effects of intravesical capsaicin treatment in patients with chronic traumatic spinal detrusor hyperreflexia.
Geirsson G; Fall M; Sullivan L
J Urol; 1995 Nov; 154(5):1825-9. PubMed ID: 7563356
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction.
Franco I; Horowitz M; Grady R; Adams RC; de Jong TP; Lindert K; Albrecht D
J Urol; 2005 Jan; 173(1):221-5. PubMed ID: 15592080
[TBL] [Abstract][Full Text] [Related]
34. Effects of ZD6169 and ZD0947, 2 potassium adenosine triphosphate channel openers, on bladder function of spinalized rats.
Abdel-Karim AM; Bialecki RA; Elhilali MM
J Urol; 2002 Aug; 168(2):837-42. PubMed ID: 12131377
[TBL] [Abstract][Full Text] [Related]
35. Desensitization of bladder sensory fibers by intravesical capsaicin or capsaicin analogs. A new strategy for treatment of urge incontinence in patients with spinal detrusor hyperreflexia or bladder hypersensitivity disorders.
Cruz F
Int Urogynecol J Pelvic Floor Dysfunct; 1998; 9(4):214-20. PubMed ID: 9795827
[TBL] [Abstract][Full Text] [Related]
36. OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity.
Rovner E; Dmochowski R; Chapple C; Thompson C; Lam W; Haag-Molkenteller C
Neurourol Urodyn; 2013 Nov; 32(8):1109-15. PubMed ID: 23389824
[TBL] [Abstract][Full Text] [Related]
37. Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study.
Giannantoni A; Di Stasi SM; Stephen RL; Navarra P; Scivoletto G; Mearini E; Porena M
J Urol; 2002 Apr; 167(4):1710-4. PubMed ID: 11912393
[TBL] [Abstract][Full Text] [Related]
38. Is Detrusor Contraction during Rapid Bladder Filling Caused by Cold or Warm Water? A Randomized, Controlled, Double-Blind Trial.
Kozomara M; Mehnert U; Seifert B; Kessler TM
J Urol; 2018 Jan; 199(1):223-228. PubMed ID: 28751267
[TBL] [Abstract][Full Text] [Related]
39. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
Schurch B; de Sèze M; Denys P; Chartier-Kastler E; Haab F; Everaert K; Plante P; Perrouin-Verbe B; Kumar C; Fraczek S; Brin MF;
J Urol; 2005 Jul; 174(1):196-200. PubMed ID: 15947626
[TBL] [Abstract][Full Text] [Related]
40. Detrusor Acontractility after Acute Spinal Cord Injury-Myth or Reality?
Bywater M; Tornic J; Mehnert U; Kessler TM
J Urol; 2018 Jun; 199(6):1565-1570. PubMed ID: 29352989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
